![Hugh Wynne-Edwards](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hugh Wynne-Edwards
Nessuna posizione attualmente
Storia della carriera di Hugh Wynne-Edwards
Precedenti posizioni note di Hugh Wynne-Edwards
Società | Posizione | Inizio | Fine |
---|---|---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Presidente | - | 08/04/2008 |
BC Research, Inc.
![]() BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada. | Fondatore | 01/01/1993 | - |
Formazione di Hugh Wynne-Edwards
University of Aberdeen | Undergraduate Degree |
Queen's University | Doctorate Degree |
Statistiche
Distribuzione geografica
Canada | 4 |
Regno Unito | 2 |
Posizioni
Chairman | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
BC Research, Inc.
![]() BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Hugh Wynne-Edwards
- Esperienza